Clayton Russell — SEC insider filings

SEC reporting owner CIK 1530072. 5 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2023-07-18 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Larimar Therapeutics, Inc. (LRMR)Chief Medical Officer51 leg · 3,322 sh · $9,999—7

Insider filings — Clayton Russell

FiledFormIssuerReported transactionsSource
2026-11-184Larimar Therapeutics, Inc. (LRMR)Purchase (P): 3,322 @ $3.01EDGAR
2026-01-274Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 25,637 @ $0 · Grant/award (A): 153,822 (derivative) @ $0EDGAR
2025-01-244Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 23,306 @ $0 · Grant/award (A): 139,838 (derivative) @ $0EDGAR
2024-01-194Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 22,500 @ $0 · Grant/award (A): 135,000 (derivative) @ $0EDGAR
2023-07-184Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 180,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1530072 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs